Alex

Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramón Polo as Senior Vice President, Head of Regulatory Affairs

Dr. Polo Brings More than 30 Years of Global Regulatory Affairs and Drug Development Experience…

New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster

Study conducted by Meiji Seika Pharma in Japan Short communication follows previously published data in…

National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation

TAIPEI, Taiwan & SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to…

Updates to FourKites’ Dynamic Ocean Help Customers Quickly Mitigate Disruptions and Combat Fees with Greater Accuracy

Robust data quality, reduced latency and customizable alerts strengthen end-to-end international shipping visibility CHICAGO--(BUSINESS WIRE)--Leading…

Westwater Resources Announces First Off-Take Agreement for Sale of Graphite from its Kellyton Plant

Westwater contracts to supply natural purified graphite anode material to SK On, a leading manufacturer…

AZUL Energy Raised ¥475 Million ($3.2 Million) in Series A Funding

SENDAI, Japan--(BUSINESS WIRE)--#Catalyst--AZUL Energy, a clean chemistry startup that develops catalysts for next-generation energy systems,…

MUFG Bank, Ltd. announces Consolidated Summary Report [under Japanese GAAP] for the nine months ended December 31, 2023

TOKYO--(BUSINESS WIRE)--MUFG Bank, Ltd. Company name: Mitsubishi UFJ Financial Group, Inc. Stock exchange listings: Tokyo,…

Square Enix Holdings Co., Ltd. Announces Financial Results for the Nine-month Period Ended December 31, 2023

TOKYO--(BUSINESS WIRE)--SQUARE ENIX HOLDINGS CO., LTD. (the “Company”) today announced consolidated financial results for the…

Insights AI Gaining Momentum in 2024, Viewed as a Huge Opportunity by Marketers, Reveals Entropik Survey

SINGAPORE--(BUSINESS WIRE)--#AI--Entropik, a leading Human Insights AI company, today announced the launch of its first…

TauRx to Present Two-Year Data from Phase III Trial of HMTM in Alzheimer’s Disease at the AD/PD™ 2024 Conference in March

ABERDEEN, Scotland--(BUSINESS WIRE)--TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD),…